Last reviewed · How we verify
Placebo for sildenafil
A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.
A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control arm in sildenafil clinical trials.
At a glance
| Generic name | Placebo for sildenafil |
|---|---|
| Sponsor | University of Colorado, Denver |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebos are inert substances used as controls in clinical trials to distinguish the pharmacological effects of an active drug from psychological or contextual effects (the placebo effect). In this case, it serves as a control comparator for sildenafil trials, allowing researchers to measure the true efficacy of sildenafil independent of patient expectations or natural disease progression.
Approved indications
- Control arm in sildenafil clinical trials
Common side effects
Key clinical trials
- Radial Shockwave Therapy for Erectile Dysfunction (NA)
- Safety of Sildenafil in Premature Infants (PHASE2)
- Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT) (PHASE2, PHASE3)
- Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD (PHASE2)
- Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer (PHASE3)
- Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension (PHASE3)
- Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile Dysfunction in PDE-5I Non Responder Patients (PHASE4)
- Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo for sildenafil CI brief — competitive landscape report
- Placebo for sildenafil updates RSS · CI watch RSS
- University of Colorado, Denver portfolio CI